 RespireRx Pharmaceuticals OTCQB:RSPI Inc announced that it has filed a provisional patent application for a novel lipid-based formulation technology LFT that may be used to improve the solubility and bioavailability of poorly soluble drugs, particularly cannabinoids. Low aqueous solubility is a major problem encountered during the formulation of drug molecules, with an estimated 70 of current drug research pipelines containing such molecules. 